| Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function M Piwecka, P Glažar, LR Hernandez-Miranda, S Memczak, SA Wolf, ... Science 357 (6357), eaam8526, 2017 | 1142 | 2017 |
| Single-cell and spatial transcriptomics: deciphering brain complexity in health and disease M Piwecka, N Rajewsky, A Rybak-Wolf Nature Reviews Neurology 19 (6), 346-362, 2023 | 152 | 2023 |
| Comprehensive analysis of microRNA expression profile in malignant glioma tissues M Piwecka, K Rolle, A Belter, AM Barciszewska, M Żywicki, M Michalak, ... Molecular oncology 9 (7), 1324-1340, 2015 | 104 | 2015 |
| The sequence and structure determine the function of mature human miRNAs K Rolle, M Piwecka, A Belter, D Wawrzyniak, J Jeleniewicz, ... PloS one 11 (3), e0151246, 2016 | 65 | 2016 |
| Mature miRNAs form secondary structure, which suggests their function beyond RISC A Belter, D Gudanis, K Rolle, M Piwecka, Z Gdaniec, ... PloS one 9 (11), e113848, 2014 | 62 | 2014 |
| Promising human brain tumors therapy with interference RNA intervention (iRNAi) K Rolle, S Nowak, E Wyszko, M Nowak, R Zukiel, R Piestrzeniewicz, ... Cancer biology & therapy 9 (5), 397-407, 2010 | 60 | 2010 |
| A multivariate analysis of patients with brain tumors treated with ATN-RNA E Wyszko, K Rolle, S Nowak, R Zukiel, M Nowak, R Piestrzeniewicz, ... Acta Pol Pharm 65 (6), 677-84, 2008 | 51 | 2008 |
| Inhibition of miR-21 in glioma cells using catalytic nucleic acids A Belter, K Rolle, M Piwecka, A Fedoruk-Wyszomirska, ... Scientific Reports 6 (1), 24516, 2016 | 38 | 2016 |
| Single-molecule fluorescence in situ hybridization (FISH) of circular RNA CDR1as C Kocks, A Boltengagen, M Piwecka, A Rybak-Wolf, N Rajewsky Circular RNAs: Methods and Protocols, 77-96, 2018 | 33 | 2018 |
| Hyperosmia, ectrodactyly, mild intellectual disability, and other defects in a male patient with an X-linked partial microduplication and overexpression of the KAL1 gene A Sowińska-Seidler, M Piwecka, E Olech, M Socha, A Latos-Bieleńska, ... Journal of Applied Genetics 56, 177-184, 2015 | 16 | 2015 |
| Nucleic acid-based technologies in therapy of malignant gliomas M Piwecka, K Rolle, E Wyszko, R Zukiel, S Nowak, M Z Barciszewska, ... Current Pharmaceutical Biotechnology 12 (11), 1805-1822, 2011 | 16 | 2011 |
| A new and efficient method for inhibition of RNA viruses by DNA interference M Nowak, E Wyszko, A Fedoruk‐Wyszomirska, H Pospieszny, ... The FEBS Journal 276 (16), 4372-4380, 2009 | 11 | 2009 |
| RNA–protein interactomes as invaluable resources to study RNA viruses: Insights from SARS CoV‐2 studies M Koliński, E Kałużna, M Piwecka Wiley Interdisciplinary Reviews: RNA 13 (6), e1727, 2022 | 7 | 2022 |
| Analyses of circRNA Expression throughout the Light-Dark Cycle Reveal a Strong Regulation of Cdr1as, Associated with Light Entrainment in the SCN A Ivanov, D Mattei, K Radscheit, AC Compagnion, JP Pett, H Herzel, ... International Journal of Molecular Sciences 23 (20), 12347, 2022 | 7 | 2022 |
| Leadzyme formed in vivo interferes with tobacco mosaic virus infection in Nicotiana tabacum E Wyszko, M Nowak, H Pospieszny, M Szymanski, J Pas, ... The FEBS journal 273 (22), 5022-5031, 2006 | 7 | 2006 |
| miR-7 controls glutamatergic transmission and neuronal connectivity in a Cdr1as-dependent manner CA Cerda-Jara, SJ Kim, G Thomas, Z Farsi, G Zolotarov, G Dube, A Deter, ... EMBO reports 25 (7), 3008-3039, 2024 | 6 | 2024 |
| ciRS-7 and miR-7 regulate ischemia-induced neuronal death via glutamatergic signaling F Scoyni, V Sitnikova, L Giudice, P Korhonen, DM Trevisan, AH de Sande, ... Cell Reports 43 (3), 2024 | 6 | 2024 |
| miR‐218 affects the ECM composition and cell biomechanical properties of glioblastoma cells M Grabowska, K Kuczyński, M Piwecka, A Rabiasz, J Zemła, P Głodowicz, ... Journal of Cellular and Molecular Medicine 26 (14), 3913-3930, 2022 | 6 | 2022 |
| Micromanaging the neuroendocrine system–A review on miR‐7 and the other physiologically relevant miRNAs in the hypothalamic–pituitary axis J Zacharjasz, M Sztachera, M Smuszkiewicz, M Piwecka FEBS letters 598 (13), 1557-1575, 2024 | 2 | 2024 |
| Method of obtaining of 4-N-furfurylcytosine and/or its derivatives, an anti-aging composition and use of 4-N-furfurylcytosine and/or its derivatives in the manufacture of anti … J Barciszewski, WT Markiewicz, E Wyszko, M Markiewicz, M Nowak, ... US Patent 8,404,660, 2013 | 2 | 2013 |
